What Hormone Levels Indicate Perimenopause?

No single hormone level reliably confirms perimenopause on its own, but rising follicle-stimulating hormone (FSH), declining anti-Müllerian hormone (AMH), and increasingly erratic estradiol are the markers clinicians look at most closely. The challenge is that these hormones swing unpredictably during the transition, so a snapshot from one blood draw can be misleading. Understanding what each marker tells you, and what it doesn’t, helps make sense of a process that unfolds over years.

FSH Is the Marker Most Clinicians Reach for First

FSH is produced by the pituitary gland and signals the ovaries to mature an egg each cycle. As the ovaries become less responsive during perimenopause, the pituitary compensates by producing more FSH. This rise begins roughly six years before the final menstrual period and eventually reaches levels about fourteen times higher than what is typically seen in men, reflecting a dramatic shift in reproductive signaling.¹

The STRAW+10 staging system, the internationally recognized framework for classifying reproductive aging, uses FSH as a key criterion. In the early menopausal transition, FSH levels are elevated but variable. By the late transition, FSH sometimes climbs into the menopausal range (above 25 IU/L based on current international pituitary standards) and sometimes drops back to levels that look normal, especially when estradiol happens to spike.² That bouncing around is exactly the problem with relying on a single FSH blood draw. Your result on a Tuesday afternoon could look completely different from a draw on a Friday morning.

A longitudinal study tracking women through the transition found that both FSH and luteinizing hormone (LH) began rising significantly about five years before menopause, with FSH continuing to climb for two to three years after the final period before plateauing.³ So FSH captures the general direction of travel well. It just cannot pin down exactly where you are at any given moment.

Estradiol Fluctuates More Than It Falls

One of the biggest misconceptions about perimenopause is that estrogen simply declines. In reality, estradiol levels during the transition are better described as chaotic. Some cycles produce estradiol surges that are higher than anything seen during regular reproductive years, while other cycles barely produce any. This instability is a hallmark of the late menopausal transition, and researchers have hypothesized that the fluctuation itself, rather than just the eventual decline, may drive many perimenopausal symptoms including mood disturbance.⁴

This erratic pattern makes estradiol a poor standalone diagnostic marker. A blood draw that catches a high estradiol spike could lead you or your clinician to conclude that everything is normal, when the very next cycle might show a dramatically different picture. The STRAW+10 criteria describe late perimenopausal cycles as featuring “extreme fluctuations in hormonal levels,” which is putting it mildly.² Estradiol tells you where your ovaries are today, not where they will be next month.

AMH Offers a Longer-Range View

Anti-Müllerian hormone comes from the pool of small follicles in your ovaries and reflects how many eggs remain. Unlike FSH, which seesaws from cycle to cycle, AMH declines in a more steady, progressive way and eventually becomes undetectable in late perimenopause.² That steadiness is what makes AMH useful as a timeline estimator rather than a snapshot diagnostic.

A study following women over time found that AMH was a stronger predictor of time to menopause than either FSH or inhibin B. Among women aged 45 to 48 with very low AMH (below 0.20 ng/mL), the median time to menopause was about six years. Women in the same age group with higher AMH (above 1.50 ng/mL) also had a median of about six years, but for younger women (35 to 39) with those higher levels, menopause was more than thirteen years away.⁵ Age and AMH together produce a much sharper prediction than either alone.

When AMH drops very low, it becomes particularly informative. Research using ultrasensitive testing found that AMH below 10 pg/mL had a positive predictive value between 78% and 97% for the final menstrual period occurring within the next three years, depending on the woman’s age.⁶ That is considerably more useful than a single FSH measurement for answering the question women most often ask: how much longer will this last?

Inhibin B and Progesterone Decline Earlier Than You Might Expect

Two hormones that get less public attention but carry real diagnostic weight are inhibin B and progesterone. Inhibin B, produced by developing ovarian follicles, shows a notable decline starting about three years before the final menstrual period, coinciding with the early rise in FSH. By one year before menopause, inhibin B is typically undetectable. Inhibin A follows a longer, steadier decline beginning at least four years out.⁷ The falling inhibin B is essentially an early signal that the ovaries are running low on responsive follicles.

Progesterone tells a related story from a different angle. You only produce meaningful progesterone after ovulation, so as cycles become increasingly anovulatory during perimenopause, progesterone output drops. By late perimenopause, more than 60% of cycles are anovulatory.⁸ But the picture is not entirely clean: about a quarter of the very long cycles (60 days or more) that characterize late perimenopause still included ovulation in the same study. The reproductive stage a woman was in predicted anovulation better than her age did, reinforcing the idea that the transition follows its own timeline rather than the calendar.

Why a Single Blood Test Often Falls Short

Given all the hormones that shift during perimenopause, you might expect a simple panel to settle the question. But a systematic review in JAMA evaluated various symptoms and tests for their ability to identify perimenopause and found that no single symptom or test was accurate enough on its own to rule it in or rule it out. Elevated FSH had a positive likelihood ratio of about 3, meaning it tripled the odds that a woman was perimenopausal compared to baseline, but that is not enough for a definitive diagnosis. Low inhibin B, hot flashes, night sweats, and vaginal dryness all contributed some diagnostic value, but the review concluded that clinicians should diagnose perimenopause based on menstrual history and age rather than relying on lab results.⁹

This may feel unsatisfying if you are looking for a definitive number. The core issue is biological: during perimenopause, your hormones are in flux by definition. A “normal” FSH reading does not mean you are not in the transition. It may just mean you caught a cycle where the pituitary happened to relax. The most informative approach is usually a combination of your symptoms, your menstrual pattern, and possibly serial measurements over several months rather than a single draw.

The STRAW+10 system captures this reality by defining the early transition primarily through changes in menstrual cycle length, specifically a persistent difference of seven or more days between consecutive cycles, rather than through any fixed hormone threshold.¹⁰ Hormones support the staging, but bleeding patterns anchor it.

LH Rises Alongside FSH, but Gets Less Attention

Luteinizing hormone tracks with FSH during the transition, though it usually receives less clinical focus. Both hormones are released by the same gland, and they remain correlated across multiple stages of the menopausal transition.¹¹ The rise in LH begins about five years before menopause, similar to FSH, but LH peaks within the first year after the final period, whereas FSH continues climbing for another year or two.³

LH also shows interesting associations with androgens like testosterone during the transition. In certain stages of the menopausal transition, higher LH is associated with higher testosterone and free testosterone.¹¹ This is relevant because some women notice changes in body hair, skin, or libido during perimenopause that relate not to estrogen but to how androgens behave relative to the declining estrogen backdrop. In the early menopausal transition, androgen levels can remain relatively stable even as estradiol drops.¹²

The Thyroid Problem

Here is where hormone testing in perimenopausal women gets genuinely tricky. Hyperthyroidism and perimenopause share many symptoms: irregular periods, sleep disruption, mood changes, sweating, and heart palpitations. About 8 to 10% of women in their forties and fifties have decreased thyroid-stimulating hormone (TSH) levels, meaning some degree of thyroid overactivity.¹³ That overlap creates a real risk that thyroid disease gets dismissed as “just menopause.”

The symptoms of thyroid dysfunction are more subtle in this age group and are frequently attributed to the menopausal transition instead.¹⁴ Several clinical organizations have recommended routine thyroid screening for perimenopausal and menopausal women, in part because a simple TSH measurement is inexpensive and can catch something treatable that would otherwise be masked by the assumption that all symptoms trace to declining ovarian function.¹⁵ If you are having your reproductive hormones checked, asking for a TSH at the same time is a reasonable move.

How Body Size and Ethnicity Shape the Hormone Picture

Perimenopausal hormone levels are not uniform across all women. Data from the SWAN (Study of Women’s Health Across the Nation) Daily Hormone Study revealed that body mass index influenced the hormonal profile of the early transition. Women with a lower BMI (under 25) tended to have shorter cycles and higher cycle-averaged LH, FSH, and progesterone metabolite levels compared with heavier women. Meanwhile, Chinese- and Japanese-American women had lower overall estrone conjugate excretion than other groups studied.¹⁶

These differences matter because a hormone value that seems elevated or depressed in one woman might be within the expected range for her body composition or ethnic background. Reference ranges on lab reports are usually derived from broad populations and may not capture this nuance. This is another reason the clinical picture, your symptoms and your cycle patterns, tends to carry more weight than raw numbers.

What Hormonal Contraception Does to the Picture

If you are on hormonal birth control, interpreting perimenopausal hormone levels becomes substantially harder. Combined oral contraceptives suppress FSH and maintain regular withdrawal bleeds, so the usual signposts, rising FSH and changing cycle length, are hidden. Guidelines suggest that confirming menopause while on hormonal methods requires coming off them for at least two weeks and then checking FSH, with two elevated readings (at or above 20 to 30 IU/L) needed. Alternatively, you can wait for cessation of natural menses: two years without periods if you are under 50, or one year if you are over 50.¹⁷

This creates a practical bind. Reliable contraception is still needed during perimenopause because ovulation can still occur, including in some very long cycles. But the very methods that provide that protection also obscure the hormonal signals you would use to track where you are in the transition. For many women, the answer is to continue contraception until the ages where menopause is statistically likely, then stop and reassess.

Cortisol and the Stress Hormone Connection

The hormonal upheaval of perimenopause does not happen in isolation from the rest of your endocrine system. Research from the Seattle Midlife Women’s Health Study found that overnight cortisol levels rose significantly during the menopausal transition, and that estrone (a form of estrogen), FSH, and testosterone together were the best set of predictors for that cortisol increase.¹⁸ Stress hormones like epinephrine and norepinephrine were also significantly linked to cortisol during this period.

What this means practically is that the sleep disruption, anxiety, and difficulty concentrating that many women experience during perimenopause are not just “in your head” and are not solely a product of declining estrogen. The shifting reproductive hormones appear to drag the stress-response system along with them. If your cortisol is chronically elevated because your reproductive axis is in upheaval, that can amplify the subjective feeling of being overwhelmed even when your external circumstances have not changed.

Menopause-Like Hormones in Other Species

Humans were long thought to be nearly unique among mammals in experiencing menopause, but recent work on wild chimpanzees documented a strikingly familiar pattern. Post-reproductive female chimpanzees older than 50 showed sharply increasing gonadotropins, the same FSH and LH surge that marks human menopause.¹⁹ The hormonal signature was not just a general age-related change. It was specifically the gonadotropin pattern that endocrinologists recognize in postmenopausal women, suggesting that the underlying ovarian depletion mechanism is shared across primate lineages. The finding does not change what perimenopause looks like in your blood work, but it does reframe the process as something deeply embedded in primate biology rather than a quirk of human longevity.

1
PubMed Central. Follicle-stimulating hormone: More than a marker for menopause: FSH as a frontier for women’s mental health
2
PubMed Central. EXECUTIVE SUMMARY of STRAW+10: Addressing the Unfinished Agenda of Staging Reproductive Aging
3
Maturitas. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density
4
PubMed Central. Naturally Occurring Changes in Estradiol Concentrations in the Menopause Transition Predict Morning Cortisol and Negative Mood in Perimenopausal Depression
5
PubMed Central. Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women
6
The Journal of Clinical Endocrinology & Metabolism. AMH as a Predictor of the Final Menstrual Period
7
Acta Obstetricia et Gynecologica Scandinavica. Inhibin A and B as markers of menopause: a five-year prospective longitudinal study of hormonal changes during the menopausal transition
8
PubMed Central. Progesterone and ovulation across stages of the transition to menopause
9
JAMA. Is This Woman Perimenopausal?
10
PubMed Central. Menstruation and the Menopause Transition
11
PubMed Central. Associations of LH and FSH with reproductive hormones depending on each stage of the menopausal transition
12
PubMed. Hormones, mood, sexuality, and the menopausal transition
13
PubMed Central. Thyroid Dysfunction in Peri- and Postmenopausal Women—Cumulative Risks
14
PubMed. Thyroid disease in the perimenopause and postmenopause period
15
PubMed Central. Thyroid Dysfunction: An Alternate Plausibility in Perimenopausal Women
16
The Journal of Clinical Endocrinology & Metabolism. Body Size and Ethnicity Are Associated with Menstrual Cycle Alterations in Women in the Early Menopausal Transition: The Study of Women’s Health across the Nation (SWAN) Daily Hormone Study
17
PubMed. Contraception during the perimenopause
18
PubMed Central. Cortisol Levels during the Menopausal Transition and Early Postmenopause: Observations from the Seattle Midlife Women’s Health Study
19
Science. Demographic and hormonal evidence for menopause in wild chimpanzees